TRCT
HKPD

Tower Research Capital (TRC)’s Cellyan Biotechnology HKPD Stock Holding History

Tower Research Capital (TRC)’s Portfolio HKPD Stock Details HKPD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-312
Closed -$399 – 5739
2025
Q2 		$399 Buy
+312
New +$386 ﹤0.01% 5038

Other funds holding HKPD

CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s HKPD Position: Q3 2025 in Review

Tower Research Capital (TRC) sold out of Cellyan Biotechnology (HKPD) in Q3 2025, closing a stake of 312 shares — an estimated $399 sold.

Tower Research Capital (TRC) first reported a position in HKPD in Q2 2025 and held it in 1 quarter. The position peaked at $399 in Q2 2025. 2 funds tracked by Wall St. Rank hold HKPD as of Q3 2025.

  • Tower Research Capital (TRC) reported no remaining Cellyan Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 312 Cellyan Biotechnology shares in Q3 2025, an estimated $399.
  • Tower Research Capital (TRC) first reported a position in Cellyan Biotechnology in Q2 2025 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Cellyan Biotechnology position peaked at $399 in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q3 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.